PATENT CLAIM ANALYSIS

Application Number: 15520183
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "186100"]

Abstract:
Provided is a recombinant replicative vaccinia virus, the virus comprising a polynucleotide encoding HSV-TK and HIV antigens. Also provided is a live vector HIV vaccine composition comprising the recombinant replicative vaccinia virus.

Claim (Index 13):
The recombinant replicative vaccinia virus of  claim 2 , wherein the recombination replicative vaccinia virus comprises a gene encoding a gp145 2M derived from 97CN001 which is the predominant HIV epidemic strain in China, and a gene encoding an HSV-TK, both genes being inserted into the TK region of the vaccinia virus Tiantan strain, and further comprises a gene encoding a gag derived from the 97CN001 inserted into the HA region of the vaccinia virus Tiantan strain.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.52174
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14602065', '12994758', '09991721', '15589857', '14632433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7292230672371679
- 35 USC 102 Novelty (BERT): 0.5326428518647772
- Combined Prediction Score: 0.7095650456999288
- Mean Citation Score: 296.864398
- Max Citation Score: 358.07013
- Similarity Product: 251.0017952480918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test